Synthetic peptide within mouse Claudin 11 aa 179-207.
Species Reactivity
Mouse, Rat
Validated Applications
IHC-Fr, IHC-P
Target Molecular Weight
Predicted band size: 22 kDa
Positive Control
Mouse Brain, Mouse Testis, Rat Brain, Rat Testis.
Conjugation
unconjugated
Clone Number
PSH25-21
Reactivity Data
Tested
Verified (internally validated)
Published
Reported in literature (not internally validated)
Predicted
Predicted reactive (based on sequence homology)
Not recommended
Not recommended (failed internal validation)
WB
IHC-P
IHC-Fr
FC(Intra)
IF-Cell
human
mouse
rat
Product Features
Form
Liquid
Concentration
1 mg/mL.(The concentration of this product may be batch-dependent)
Lot Concentration Lookup
Storage Instructions
Store at 2-8℃. Avoid freeze.
Storage Buffer
PBS (pH7.4).
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
Target
Function
The protein encoded by this gene belongs to the claudin family of tight junction associated proteins and is a major component of central nervous system myelin that is necessary for normal CNS function, hearing, and spermatogenesis. There is growing evidence that the protein determines the permeability between layers of myelin sheaths and, with its expression highly regulated during development, may play an important role in cellular proliferation and migration. In addition, the protein is a candidate autoantigen in the development of autoimmune demyelinating disease. Finally, experiments in Cldn11-null mice demonstrate that behavioral phenotypes in open field tests, as well as defects in sound lateralization, accompany changes in neurotransmitter levels in the amygdala/ventral hippocampus and auditory brainstem. This study reveals a molecular mechanism by which changes to myelin membrane properties in the absence of degenerative pathology, could lead to neuropsychiatric disease in humans.
Background References
1. Liu K et al. Unveiling the oncogenic role of CLDN11-secreting fibroblasts in gastric cancer peritoneal metastasis through single-cell sequencing and experimental approaches. Int Immunopharmacol. 2024 Mar
2. Yang L et al. CLDN11 deficiency upregulates FOXM1 to facilitate breast tumor progression through hedgehog signaling pathway. J Mol Histol. 2024 Dec